BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonnet U, Claus B, Schaefer M, Kuhn J, Nyhuis P, Scherbaum N, Brüne M, Wakili V, Juckel G. Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area. Pharmacopsychiatry 2021. [PMID: 34530483 DOI: 10.1055/a-1559-3904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Borovcanin MM, Vesic K, Balcioglu YH, Mijailović NR. Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution. Front Psychiatry 2022;13:1052710. [DOI: 10.3389/fpsyt.2022.1052710] [Reference Citation Analysis]
2 Gouda AS, Mégarbane B. Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins. JPM 2022;12:1487. [DOI: 10.3390/jpm12091487] [Reference Citation Analysis]
3 Bonnet U, Juckel G. COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review. J Clin Psychopharmacol 2022. [PMID: 35420565 DOI: 10.1097/JCP.0000000000001543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Veerman SRT, Moscou T, Bogers JPAM, Cohen D, Schulte PFJ. Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study. Acta Psychiatr Scand 2022. [PMID: 35322409 DOI: 10.1111/acps.13428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mueller JK, Riederer P, Müller WE. Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? Pharmacopsychiatry 2022;55:7-15. [DOI: 10.1055/a-1717-2381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bauer M, Juckel G. Covid-19: Contributions from Psychopharmacology. Pharmacopsychiatry 2022;55:5-6. [DOI: 10.1055/a-1720-8855] [Reference Citation Analysis]